| 发明名称 |
Imidazoquinolines as dual lipid kinase and mTOR inhibitors |
| 摘要 |
<p>The invention relates to the use of compounds of formula (I) in the treatment of mammalian target of rapamycin (mTOR) kinase dependent diseases, methods of use of said compounds in the treatment of said diseases in a warm-blooded animal, especially a human, pharmaceutical preparations comprising said compounds for the treatment of said diseases and said compounds for use in the treatment of said diseases.</p> |
| 申请公布号 |
AU2008218806(A1) |
申请公布日期 |
2008.08.28 |
| 申请号 |
AU20080218806 |
申请日期 |
2008.02.19 |
| 申请人 |
NOVARTIS AG |
发明人 |
PETER FINAN;SASKIA MARIA BRACHMANN;SAUVEUR-MICHEL MAIRA;CHRISTINE FRITSCH;CARLOS GARCIA-ECHEVERRIA;PAUL LESLIE NICKLIN;LEON MURPHY |
| 分类号 |
A61K31/4745;A61P7/00;A61P9/00;A61P11/00;A61P25/00;A61P27/02;A61P31/04;A61P31/12;A61P35/00;A61P37/00;A61P43/00 |
主分类号 |
A61K31/4745 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
